These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 36454825)

  • 1. Vaccination induces HIV broadly neutralizing antibody precursors in humans.
    Leggat DJ; Cohen KW; Willis JR; Fulp WJ; deCamp AC; Kalyuzhniy O; Cottrell CA; Menis S; Finak G; Ballweber-Fleming L; Srikanth A; Plyler JR; Schiffner T; Liguori A; Rahaman F; Lombardo A; Philiponis V; Whaley RE; Seese A; Brand J; Ruppel AM; Hoyland W; Yates NL; Williams LD; Greene K; Gao H; Mahoney CR; Corcoran MM; Cagigi A; Taylor A; Brown DM; Ambrozak DR; Sincomb T; Hu X; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Mullen TM; Kubitz M; Groschel B; Maenza J; Kolokythas O; Khati N; Bethony J; Crotty S; Roederer M; Karlsson Hedestam GB; Tomaras GD; Montefiori D; Diemert D; Koup RA; Laufer DS; McElrath MJ; McDermott AB; Schief WR
    Science; 2022 Dec; 378(6623):eadd6502. PubMed ID: 36454825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice.
    Cottrell CA; Hu X; Lee JH; Skog P; Luo S; Flynn CT; McKenney KR; Hurtado J; Kalyuzhniy O; Liguori A; Willis JR; Landais E; Raemisch S; Chen X; Baboo S; Himansu S; Diedrich JK; Duan H; Cheng C; Schiffner T; Bader DLV; Kulp DW; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Sincomb T; Kubitz M; Mullen TM; Yates JR; Paulson JC; Mascola JR; Alt FW; Briney B; Sok D; Schief WR
    Sci Transl Med; 2024 May; 16(748):eadn0223. PubMed ID: 38753806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.
    Steichen JM; Phung I; Salcedo E; Ozorowski G; Willis JR; Baboo S; Liguori A; Cottrell CA; Torres JL; Madden PJ; Ma KM; Sutton HJ; Lee JH; Kalyuzhniy O; Allen JD; Rodriguez OL; Adachi Y; Mullen TM; Georgeson E; Kubitz M; Burns A; Barman S; Mopuri R; Metz A; Altheide TK; Diedrich JK; Saha S; Shields K; Schultze SE; Smith ML; Schiffner T; Burton DR; Watson CT; Bosinger SE; Crispin M; Yates JR; Paulson JC; Ward AB; Sok D; Crotty S; Schief WR
    Science; 2024 May; 384(6697):eadj8321. PubMed ID: 38753769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
    Schiffner T; Phung I; Ray R; Irimia A; Tian M; Swanson O; Lee JH; Lee CD; Marina-Zárate E; Cho SY; Huang J; Ozorowski G; Skog PD; Serra AM; Rantalainen K; Allen JD; Baboo S; Rodriguez OL; Himansu S; Zhou J; Hurtado J; Flynn CT; McKenney K; Havenar-Daughton C; Saha S; Shields K; Schultze S; Smith ML; Liang CH; Toy L; Pecetta S; Lin YC; Willis JR; Sesterhenn F; Kulp DW; Hu X; Cottrell CA; Zhou X; Ruiz J; Wang X; Nair U; Kirsch KH; Cheng HL; Davis J; Kalyuzhniy O; Liguori A; Diedrich JK; Ngo JT; Lewis V; Phelps N; Tingle RD; Spencer S; Georgeson E; Adachi Y; Kubitz M; Eskandarzadeh S; Elsliger MA; Amara RR; Landais E; Briney B; Burton DR; Carnathan DG; Silvestri G; Watson CT; Yates JR; Paulson JC; Crispin M; Grigoryan G; Ward AB; Sok D; Alt FW; Wilson IA; Batista FD; Crotty S; Schief WR
    Nat Immunol; 2024 Jun; 25(6):1073-1082. PubMed ID: 38816615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors.
    Luo S; Jing C; Ye AY; Kratochvil S; Cottrell CA; Koo JH; Chapdelaine Williams A; Francisco LV; Batra H; Lamperti E; Kalyuzhniy O; Zhang Y; Barbieri A; Manis JP; Haynes BF; Schief WR; Batista FD; Tian M; Alt FW
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2217883120. PubMed ID: 36574685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models.
    Wang X; Cottrell CA; Hu X; Ray R; Bottermann M; Villavicencio PM; Yan Y; Xie Z; Warner JE; Ellis-Pugh JR; Kalyuzhniy O; Liguori A; Willis JR; Menis S; Rämisch S; Eskandarzadeh S; Kubitz M; Tingle R; Phelps N; Groschel B; Himansu S; Carfi A; Kirsch KH; Weldon SR; Nair U; Schief WR; Batista FD
    Sci Immunol; 2024 May; 9(95):eadn0622. PubMed ID: 38753808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement.
    Liu Q; Zhang P; Miao H; Lin Y; Kwon YD; Kwong PD; Rikhtegaran-Tehrani Z; Seaman MS; DeVico AL; Sajadi MM; Lusso P
    J Virol; 2021 May; 95(12):. PubMed ID: 33827946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.
    Cohen KW; De Rosa SC; Fulp WJ; deCamp AC; Fiore-Gartland A; Mahoney CR; Furth S; Donahue J; Whaley RE; Ballweber-Fleming L; Seese A; Schwedhelm K; Geraghty D; Finak G; Menis S; Leggat DJ; Rahaman F; Lombardo A; Borate BR; Philiponis V; Maenza J; Diemert D; Kolokythas O; Khati N; Bethony J; Hyrien O; Laufer DS; Koup RA; McDermott AB; Schief WR; McElrath MJ
    Sci Transl Med; 2023 May; 15(697):eadf3309. PubMed ID: 37224227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
    van Schooten J; van Haaren MM; Li H; McCoy LE; Havenar-Daughton C; Cottrell CA; Burger JA; van der Woude P; Helgers LC; Tomris I; Labranche CC; Montefiori DC; Ward AB; Burton DR; Moore JP; Sanders RW; Crotty S; Shaw GM; van Gils MJ
    PLoS Pathog; 2021 Aug; 17(8):e1009736. PubMed ID: 34432859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice.
    Galkin A; Chen Y; Guenaga J; O'Dell S; Acevedo R; Steinhardt JJ; Wang Y; Wilson R; Chiang CI; Doria-Rose N; Grishaev AV; Mascola JR; Li Y
    J Immunol; 2020 Mar; 204(6):1543-1561. PubMed ID: 32066595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.
    Schorcht A; van den Kerkhof TLGM; Cottrell CA; Allen JD; Torres JL; Behrens AJ; Schermer EE; Burger JA; de Taeye SW; Torrents de la Peña A; Bontjer I; Gumbs S; Ozorowski G; LaBranche CC; de Val N; Yasmeen A; Klasse PJ; Montefiori DC; Moore JP; Schuitemaker H; Crispin M; van Gils MJ; Ward AB; Sanders RW
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
    Caniels TG; Medina-Ramírez M; Zhang J; Sarkar A; Kumar S; LaBranche A; Derking R; Allen JD; Snitselaar JL; Capella-Pujol J; Sánchez IDM; Yasmeen A; Diaz M; Aldon Y; Bijl TPL; Venkatayogi S; Martin Beem JS; Newman A; Jiang C; Lee WH; Pater M; Burger JA; van Breemen MJ; de Taeye SW; Rantalainen K; LaBranche C; Saunders KO; Montefiori D; Ozorowski G; Ward AB; Crispin M; Moore JP; Klasse PJ; Haynes BF; Wilson IA; Wiehe K; Verkoczy L; Sanders RW
    Cell Rep Med; 2023 Apr; 4(4):101003. PubMed ID: 37044090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.
    van Haaren MM; McCoy LE; Torres JL; Lee W; Cottrell CA; Copps JL; van der Woude P; Yasmeen A; de Taeye SW; Torrents de la Peña A; Moore JP; Burton DR; Klasse PJ; Ward AB; Sanders RW; van Gils MJ
    J Virol; 2021 Aug; 95(17):e0009421. PubMed ID: 34076487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
    Duc Dang A; Dinh Vu T; Hai Vu H; Thanh Ta V; Thi Van Pham A; Thi Ngoc Dang M; Van Le B; Huu Duong T; Van Nguyen D; Lawpoolsri S; Chinwangso P; McLellan JS; Hsieh CL; Garcia-Sastre A; Palese P; Sun W; Martinez JL; Gonzalez-Dominguez I; Slamanig S; Manuel Carreño J; Tcheou J; Krammer F; Raskin A; Minh Vu H; Cong Tran T; Mai Nguyen H; Mercer LD; Raghunandan R; Lal M; White JA; Hjorth R; Innis BL; Scharf R
    Vaccine; 2022 Jun; 40(26):3621-3632. PubMed ID: 35577631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice.
    Melzi E; Willis JR; Ma KM; Lin YC; Kratochvil S; Berndsen ZT; Landais EA; Kalyuzhniy O; Nair U; Warner J; Steichen JM; Kalyuzhniy A; Le A; Pecetta S; Perez M; Kirsch K; Weldon SR; Falcone S; Himansu S; Carfi A; Sok D; Ward AB; Schief WR; Batista FD
    Immunity; 2022 Nov; 55(11):2168-2186.e6. PubMed ID: 36179690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.
    Willis JR; Berndsen ZT; Ma KM; Steichen JM; Schiffner T; Landais E; Liguori A; Kalyuzhniy O; Allen JD; Baboo S; Omorodion O; Diedrich JK; Hu X; Georgeson E; Phelps N; Eskandarzadeh S; Groschel B; Kubitz M; Adachi Y; Mullin TM; Alavi NB; Falcone S; Himansu S; Carfi A; Wilson IA; Yates JR; Paulson JC; Crispin M; Ward AB; Schief WR
    Immunity; 2022 Nov; 55(11):2149-2167.e9. PubMed ID: 36179689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.
    Xie Z; Lin YC; Steichen JM; Ozorowski G; Kratochvil S; Ray R; Torres JL; Liguori A; Kalyuzhniy O; Wang X; Warner JE; Weldon SR; Dale GA; Kirsch KH; Nair U; Baboo S; Georgeson E; Adachi Y; Kubitz M; Jackson AM; Richey ST; Volk RM; Lee JH; Diedrich JK; Prum T; Falcone S; Himansu S; Carfi A; Yates JR; Paulson JC; Sok D; Ward AB; Schief WR; Batista FD
    Science; 2024 May; 384(6697):eadk0582. PubMed ID: 38753770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.
    Ray R; Schiffner T; Wang X; Yan Y; Rantalainen K; Lee CD; Parikh S; Reyes RA; Dale GA; Lin YC; Pecetta S; Giguere S; Swanson O; Kratochvil S; Melzi E; Phung I; Madungwe L; Kalyuzhniy O; Warner J; Weldon SR; Tingle R; Lamperti E; Kirsch KH; Phelps N; Georgeson E; Adachi Y; Kubitz M; Nair U; Crotty S; Wilson IA; Schief WR; Batista FD
    Nat Immunol; 2024 Jun; 25(6):1083-1096. PubMed ID: 38816616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial.
    Madhi SA; Koen AL; Izu A; Fairlie L; Cutland CL; Baillie V; Padayachee SD; Dheda K; Barnabas SL; Bhorat QE; Briner C; Aley PK; Bhikha S; Hermanus T; Horne E; Jose A; Kgagudi P; Lambe T; Masenya M; Masilela M; Mkhize N; Moultrie A; Mukendi CK; Moyo-Gwete T; Nana AJ; Nzimande A; Patel F; Rhead S; Taoushanis C; Thombrayil A; van Eck S; Voysey M; Villafana TL; Vekemans J; Gilbert SC; Pollard AJ; Moore PL; Kwatra G;
    Lancet HIV; 2021 Sep; 8(9):e568-e580. PubMed ID: 34416193
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.